News | April 21, 2023
SÜDPACK’s PharmaGuard blister concept to add to sustainability
SÜDPACK is setting standards in terms of both performance and sustainability
SÜDPACK is setting standards in terms of both performance and sustainability
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The survey inspected ambulances operating throughout the city
Proposed combination enhances Pfizer’s position as a leading company in oncology
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
Subscribe To Our Newsletter & Stay Updated
